Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001680329-25-000010
Filing Date
2025-11-14
Accepted
2025-11-14 17:20:05
Documents
1
Period of Report
2025-11-12

Document Format Files

Seq Description Document Type Size
1 form4-11142025_051101.html 4  
1 form4-11142025_051101.xml 4 7174
  Complete submission text file 0001680329-25-000010.txt   8695
Mailing Address 500 WARREN CORPORATE CENTER DRIVE WARREN NJ 07059
Business Address 500 WARREN CORPORATE CENTER DRIVE WARREN NJ 07059 9082227000
PTC THERAPEUTICS, INC. (Issuer) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O PAREXEL INTERNATIONAL CORPORATION 195 WEST STREET WALTHAM MA 02451
Business Address
Reeve Emma (Reporting) CIK: 0001680329 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35969 | Film No.: 251488257